A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Efficacy and Safety of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy
Phase of Trial: Phase II
Latest Information Update: 05 May 2017
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Recro Pharma
- 14 Aug 2015 Results published in Recro Pharma media release.
- 24 Jul 2015 Additional safety and efficacy results published in Recro Pharma media release.
- 17 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History